Correlation Between Regenxbio and Denali Therapeutics
Can any of the company-specific risk be diversified away by investing in both Regenxbio and Denali Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regenxbio and Denali Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regenxbio and Denali Therapeutics, you can compare the effects of market volatilities on Regenxbio and Denali Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regenxbio with a short position of Denali Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regenxbio and Denali Therapeutics.
Diversification Opportunities for Regenxbio and Denali Therapeutics
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Regenxbio and Denali is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Regenxbio and Denali Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Denali Therapeutics and Regenxbio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regenxbio are associated (or correlated) with Denali Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Denali Therapeutics has no effect on the direction of Regenxbio i.e., Regenxbio and Denali Therapeutics go up and down completely randomly.
Pair Corralation between Regenxbio and Denali Therapeutics
Given the investment horizon of 90 days Regenxbio is expected to under-perform the Denali Therapeutics. In addition to that, Regenxbio is 1.03 times more volatile than Denali Therapeutics. It trades about -0.04 of its total potential returns per unit of risk. Denali Therapeutics is currently generating about 0.05 per unit of volatility. If you would invest 1,837 in Denali Therapeutics on September 3, 2024 and sell it today you would earn a total of 726.00 from holding Denali Therapeutics or generate 39.52% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Regenxbio vs. Denali Therapeutics
Performance |
| Timeline |
| Regenxbio |
| Denali Therapeutics |
Regenxbio and Denali Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Regenxbio and Denali Therapeutics
The main advantage of trading using opposite Regenxbio and Denali Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regenxbio position performs unexpectedly, Denali Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denali Therapeutics will offset losses from the drop in Denali Therapeutics' long position.| Regenxbio vs. Day One Biopharmaceuticals | Regenxbio vs. Replimune Group | Regenxbio vs. Mirum Pharmaceuticals | Regenxbio vs. Rocket Pharmaceuticals |
| Denali Therapeutics vs. DiaMedica Therapeutics | Denali Therapeutics vs. Lyra Therapeutics | Denali Therapeutics vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |